enGene Holdings Inc. (ENGN) vs LENZ Therapeutics, Inc. (LENZ)

A side-by-side comparison of enGene Holdings Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ENGN vs LENZ

growth of $100 · dividends reinvested · last 3y
ENGN -90.7% (-54.6%/yr)LENZ -35.1% (-13.4%/yr)LENZ compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202420252026$9$65
ENGN LENZ

ENGN vs LENZ: by the numbers

  • •ENGN is the larger company ($122M vs $119M market cap).
  • •Both run net losses; ENGN's is the smaller (0.00% vs -586.74% net margin).

Metrics side by side

Valuation

MetricENGNLENZ
P/S ratioN/A5.54
P/B ratio0.530.54

Profitability

MetricENGNLENZ
Gross margin0.00%90.14%
Operating margin0.00%-477.46%
Net margin0.00%-586.74%
ROE-2.13%-57.47%
ROIC-1.78%-61.84%

Growth (annualized)

MetricENGNLENZ
Total return CAGR (5Y)N/A-35.49%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.